methyl 3-nitro-4-[[(trifluoromethyl)sulfonyl]oxy]benzoate | 123027-96-3

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: methyl 3-nitro-4-[[(trifluoromethyl)sulfonyl]oxy]benzoate
• 英文别名: 3-nitro-4-trifluoromethanesulfonyloxy-benzoic acid methyl ester；methyl 3-nitro-4-(trifluoromethylsulfonyloxy)benzoate
• CAS: 123027-96-3
• 化学式: C₉H₆F₃NO₇S
• 分子量: 329.21
• InChiKey: RPKQXHNACTWKQY-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.4
• 重原子数：
  21
• 可旋转键数：
  4
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.22
• 拓扑面积：
  124
• 氢给体数：
  0
• 氢受体数：
  10

反应信息

• 作为反应物：
  描述：

  methyl 3-nitro-4-[[(trifluoromethyl)sulfonyl]oxy]benzoate 在 四(三苯基膦)钯 potassium phosphate 、 水 、 氰基亚甲基三正丁基膦 、 sodium hydroxide 、 亚磷酸三乙酯 作用下， 以 乙醇 、 N,N-二甲基甲酰胺 、 甲苯 为溶剂， 生成 9-isopropyl-9H-carbazole-2-carboxylic acid
  参考文献：
  名称：

  EP2119704

  摘要：

  公开号：
• 作为产物：
  描述：

  4-carbomethoxyphenyl triflate 在 硫酸 、 硝酸 作用下， 反应 14.0h， 以87%的产率得到methyl 3-nitro-4-[[(trifluoromethyl)sulfonyl]oxy]benzoate
  参考文献：
  名称：

  Palladium-catalyzed synthesis of 2-substituted indoles

  摘要：

  DOI：

  10.1021/jo00286a014

文献信息

• Aminoalcohol derivatives
  申请人：Hattori Kouji

  公开号：US20050137236A1

  公开（公告）日：2005-06-23

  The present invention relates to a compound formula[I]: wherein X is bond, —CH 2 —, —O— or —NH—, R 1 and R 12 are each independently hydrogen, halogen, lower alkyl, etc., R 2 is hydrogen or optionally substituted lower alkyl, R 3 is hydrogen or an amino protective group, R 4 , R 5 and R 6 are each independently hydrogen or optionally substituted lower alkyl, R 7 is -Z-R 13 , in which Z is bond, etc., and R 13 is carboxy, lower alkoxycarbonyl, (lower alkylsulfonyl)carbamoyl or lower alkanoylsulfamoyl, R 8 is —Y—R 9 , in which Y is bond, —CH 2 —, —O—, —S—, etc., and R 9 is hydrogen, lower alkyl, cyclo(lower)alkyl, etc., and R 11 is hydrogen, lower alkyl, lower alkoxy, etc., or a salt thereof. The compound [I] of the present invention and pharmaceutically acceptable salts thereof are useful for the prophylactic and/or the therapeutic treatment of pollakiurea or urinary incontinence.

  本发明涉及一种化合物公式[I]： 其中 X是键，—CH 2 —，—O—或—NH—， R 1 和R 12 分别独立地是氢，卤素，较低的烷基等， R 2 是氢或可选择地取代的较低烷基， R 3 是氢或氨基保护基， R 4 ，R 5 和R 6 分别独立地是氢或可选择地取代的较低烷基， R 7 是-Z-R 13 ，在其中Z是键等，而 R 13 是羧基，较低的烷氧羰基，（较低的烷基磺酰）氨基甲酰或较低的烷酰磺酰氨基， R 8 是—Y—R 9 ，在其中 Y是键，—CH 2 —，—O—，—S—等，而 R 9 是氢，较低的烷基，环（较低）烷基等，而 R 11 是氢，较低的烷基，较低的烷氧基等，或其盐。本发明的化合物[I]及其药学上可接受的盐对于预防和/或治疗尿频或尿失禁具有用处。
• HETEROARYLAMIDE LOWER CARBOXYLIC ACID DERIVATIVE
  申请人：Machinaga Nobuo

  公开号：US20090324581A1

  公开（公告）日：2009-12-31

  To provide a novel compound which has S1P receptor agonistic activity, exhibits excellent immunosuppressing effect, gives less adverse side effects, and can be orally administered. The invention provides a compound represented by general formula (I) (wherein A is a single bond, —O—, or —CH 2 —; R 1 represents a hydrogen atom or a C 1 -C 6 alkyl group, and V represents any one group selected from among the following groups (1) to (3): (1) -G 1 -, (2) -G 2 -N(R 2 )-G 3 -, and (3) a group represented by formula 2, wherein each of Z 1 and Z 2 represents a hydrogen atom or a C 1 -C 6 alkyl group, Z 3 represents a hydrogen or the like, Q represents —CH 2 —O— or the like, and Y represents a group represented by formula 3, a salt thereof, or a solvate thereof.

  提供一种新型化合物，具有S1P受体激动活性，表现出优异的免疫抑制效果，产生较少的不良副作用，并可口服。本发明提供一种由通式（I）表示的化合物（其中A是单键，-O-或-CH2-；R1表示氢原子或C1-C6烷基基团，V表示从以下组（1）至（3）中选择的任一组：（1）-G1-，（2）-G2-N（R2）-G3-，以及（3）由式2表示的组，其中Z1和Z2分别表示氢原子或C1-C6烷基基团，Z3表示氢或类似物，Q表示-CH2-O-或类似物，Y表示由式3表示的基团，其盐或溶剂化物。
• INSECTICIDAL COMPOUNDS
  申请人：Jung Pierre

  公开号：US20100056639A1

  公开（公告）日：2010-03-04

  A compound of formula (I): wherein A 1 , A 2 , A 3 , A 4 , R 1 , R 2 , G 1 , G 2 , Q 1 and Q 2 are as defined in claim 1 ; or a salt or N-oxide thereof. Furthermore, the present invention relates to processes and intermediates for preparing compounds of formula (I), to insecticidal, acaricidal, molluscicidal and nematicidal compositions comprising them and to methods of using them to combat and control insect, acarine, mollusc and nematode pests.

  公式(I)的化合物：其中A1，A2，A3，A4，R1，R2，G1，G2，Q1和Q2如权利要求1所定义；或其盐或N-氧化物。此外，本发明涉及制备公式(I)化合物的过程和中间体，含有它们的杀虫剂，杀螨剂，杀软体动物剂和杀线虫剂组合物，以及使用它们对抗和控制昆虫，螨虫，软体动物和线虫害的方法。
• Insecticidal compounds
  申请人：Jung Pierre

  公开号：US08389766B2

  公开（公告）日：2013-03-05

  A compound of formula (I): wherein A1, A2, A3, A4, R1, R2, G1, G2, Q1 and Q2 are as defined in claim 1; or a salt or N-oxide thereof. Furthermore, the present invention relates to processes and intermediates for preparing compounds of formula (I), to insecticidal, acaricidal, molluscicidal and nematicidal compositions comprising them and to methods of using them to combat and control insect, acarine, mollusc and nematode pests.

  公式（I）的化合物：其中A1，A2，A3，A4，R1，R2，G1，G2，Q1和Q2如权利要求1所定义；或其盐或N-氧化物。此外，本发明涉及制备公式（I）化合物的过程和中间体，以及包含它们的杀虫剂、杀螨剂、灭螺剂和灭线虫剂组合物，以及使用它们来对抗和控制昆虫、螨虫、软体动物和线虫害的方法。
• ACYLGUANIDINE DERIVATIVE
  申请人：Kinoyama Isao

  公开号：US20100324017A1

  公开（公告）日：2010-12-23

  An object of the present invention is to provide a novel and excellent agent for treating or preventing dementia, schizophrenia and the like, based on the 5-HT 5A receptor modulating action. It was confirmed that a compound characterized by a structure that a tricyclic hetero ring having a pyrrole ring at the center and guanidine are bonded via a carbonyl group has a potent 5-HT 5A receptor modulating action and an excellent pharmacological action based thereon, and thus, it was found that the compound can be an excellent agent for treating or preventing dementia, schizophrenia, bipolar disorder, or attention deficit hyperactivity disorder, particularly for memory-related functional disorders such as cognitive impairments including dementia and schizophrenia, thereby completing the present invention.

  本发明的目的是提供一种基于5-HT5A受体调节作用的新型优良的治疗或预防痴呆症、精神分裂症等药剂。经证实，一种以三环杂环在中心具有吡咯环，并通过羰基结合了胍的结构特征化合物具有强效的5-HT5A受体调节作用和基于此的优良药理作用，因此，发现该化合物可以成为治疗或预防痴呆症、精神分裂症、躁郁症或注意力缺陷多动障碍等的优良药剂，特别是对于认知障碍包括痴呆症和精神分裂症等的记忆相关功能障碍，从而完成了本发明。